Johnson & Johnson (JNJ) Capital Expenditures (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Capital Expenditures data on file, last reported at $1.0 billion in Q1 2026.

• Quarterly Capital Expenditures rose 31.95% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 billion (up 15.28% YoY) and the FY2025 annual result came in at $4.8 billion, up 9.22% from the prior year.
• Capital Expenditures retreated to $1.0 billion in Q1 2026 per JNJ's latest filing, from $1.8 billion in the prior quarter.
• The five-year high for Capital Expenditures was $1.8 billion in Q4 2025, with the low at $607.0 million in Q2 2022.
• Average Capital Expenditures over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2025.
• Year-over-year, Capital Expenditures surged 42.17% in 2023 and dropped 13.17% in 2024.
• Johnson & Johnson's Capital Expenditures stood at $607.0 million in 2022, then jumped by 161.78% to $1.6 billion in 2023, then climbed by 1.45% to $1.6 billion in 2024, then climbed by 13.96% to $1.8 billion in 2025, then sank by 42.9% to $1.0 billion in 2026.
• Business Quant data shows JNJ's Capital Expenditures at $1.0 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.2 billion in Q3 2025.